Eli Lilly and Company et al v. Aurobindo Pharma Limited et al

1:2022-cv-01114
ANDA
Bio-Tech
Cause of ActionLogin To View
Appeal NumberLogin To View
Filing DateAug 24, 2022
Termination DateLogin To View
Case LengthLogin To View
Technology Center-
Plaintiff
2
Incyte
Defendant
3
Aurobindo Pharma
Msn Laboratories
ANDA report image

Empower your practice with Patexia ANDA IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a ANDA Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.